curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Investigating and Modelling the Natural History of Dengue in Hospitalised Patients to Improve Future Research

by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials

​ Conditions: Dengue Sponsors: Liverpool School of Tropical Medicine; Nagasaki University; Pasteur Institute, Nha Trang Not yet recruiting Conditions: Dengue Sponsors: Liverpool School of Tropical Medicine; Nagasaki University; Pasteur Institute, Nha Trang Not yet...

Evaluation of the Melanin-Adjusted Blood Oxygen Sensor (MABOS) in ICU Settings

by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials

​ Conditions: Hypoxemia Interventions: Device: MABOS Sponsors: University of North Carolina, Chapel Hill Recruiting Conditions: Hypoxemia Interventions: Device: MABOS Sponsors: University of North Carolina, Chapel Hill...

Identification of Changes in Cancer-related Fatigue and Physical Activity and Their Association in Patients With Inoperable Lung Cancer: a Longitudinal Observational Study

by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials

​ Conditions: Lung Cancer (Locally Advanced or Metastatic) Sponsors: University Hospital, Ghent Not yet recruiting Conditions: Lung Cancer (Locally Advanced or Metastatic) Sponsors: University Hospital, Ghent Not yet recruiting 

TFESI and Neuropathic Pain in Lumbosacral Radiculopathy

by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials

​ Conditions: Lumbosacral Radiculopathy; Neuropathic Pain From Lumbosacral Radiculopathy; Disc Herniation With Radiculopathy Interventions: Procedure: Transforaminal Epidural Steroid Injections Sponsors: Marmara University Recruiting Conditions: Lumbosacral...

A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma

by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials

​ Conditions: Metastatic Colorectal Carcinoma Interventions: Drug: LBL-024 for Injection; Drug: Bevacizumab injection; Drug: Oxaliplatin injection; Drug: Capecitabine tablets; Drug: Fruquintinib Capsules Sponsors: Nanjing Leads Biolabs Co.,Ltd; Sun Yat-Sen University...
« Older Entries
Next Entries »

Recent Posts

  • PD-1 Blockade Alone Versus in Combination With Chemotherapy as First Line Therapy in Females With Advanced NSCLC & PD-L1 Expression ≥50%
  • Turkish Adaptation of the Perceived Barriers to Exercise Questionnaire for Office Workers
  • Ocular Fluid Work-up in Presumed Trematode Induced Granulomatous Uveitis
  • Optical Coherence Tomography-Assisted Strategy for Interventional Management of Symptomatic Carotid Stenosis (OASIS-C)
  • Postoperative Pain and Quality of Life Following Root Canal Treatment With Two Different Sealers

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®